Leonurine Attenuates Obesity-Related Vascular Dysfunction and Inflammation

Oxidative stress in adipose tissue is a crucial pathogenic mechanism of obesity-associated cardiovascular diseases. Chronic low-grade inflammation caused by obesity increases ROS production and dysregulation of adipocytokines. Leonurine (LEO) is an active alkaloid extracted from Herba Leonuri and pl...

Full description

Bibliographic Details
Main Authors: Xiao-Dong Shi, Jia-Xin Zhang, Xi-De Hu, Tao Zhuang, Ning Lu, Cheng-Chao Ruan
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/11/7/1338
_version_ 1797433901329678336
author Xiao-Dong Shi
Jia-Xin Zhang
Xi-De Hu
Tao Zhuang
Ning Lu
Cheng-Chao Ruan
author_facet Xiao-Dong Shi
Jia-Xin Zhang
Xi-De Hu
Tao Zhuang
Ning Lu
Cheng-Chao Ruan
author_sort Xiao-Dong Shi
collection DOAJ
description Oxidative stress in adipose tissue is a crucial pathogenic mechanism of obesity-associated cardiovascular diseases. Chronic low-grade inflammation caused by obesity increases ROS production and dysregulation of adipocytokines. Leonurine (LEO) is an active alkaloid extracted from Herba Leonuri and plays a protective role in the cardiovascular system. The present study tested whether LEO alleviates inflammation and oxidative stress, and improves vascular function in an obese mouse model. Here, we found that obesity leads to inflammation and oxidative stress in epididymal white adipose tissue (EWAT), as well as vascular dysfunction. LEO significantly improved inflammation and oxidative stress both in vivo and in vitro. Obesity-induced vascular dysfunction was also improved by LEO as evidenced by the ameliorated vascular tone and decreased mesenteric artery fibrosis. Using mass spectrometry, we identified YTHDF1 as the direct target of LEO. Taken together, we demonstrated that LEO improves oxidative stress and vascular remodeling induced by obesity and targets YTHDF1, raising the possibility of LEO treating other obesity-related metabolic syndromes.
first_indexed 2024-03-09T10:23:30Z
format Article
id doaj.art-c3fac70a8a154db499b00e87c3aa852e
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T10:23:30Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-c3fac70a8a154db499b00e87c3aa852e2023-12-01T21:49:56ZengMDPI AGAntioxidants2076-39212022-07-01117133810.3390/antiox11071338Leonurine Attenuates Obesity-Related Vascular Dysfunction and InflammationXiao-Dong Shi0Jia-Xin Zhang1Xi-De Hu2Tao Zhuang3Ning Lu4Cheng-Chao Ruan5Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, ChinaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaDepartment of Physiology and Pathophysiology, School of Basic Medical Sciences, Fudan University, Shanghai 200032, ChinaOxidative stress in adipose tissue is a crucial pathogenic mechanism of obesity-associated cardiovascular diseases. Chronic low-grade inflammation caused by obesity increases ROS production and dysregulation of adipocytokines. Leonurine (LEO) is an active alkaloid extracted from Herba Leonuri and plays a protective role in the cardiovascular system. The present study tested whether LEO alleviates inflammation and oxidative stress, and improves vascular function in an obese mouse model. Here, we found that obesity leads to inflammation and oxidative stress in epididymal white adipose tissue (EWAT), as well as vascular dysfunction. LEO significantly improved inflammation and oxidative stress both in vivo and in vitro. Obesity-induced vascular dysfunction was also improved by LEO as evidenced by the ameliorated vascular tone and decreased mesenteric artery fibrosis. Using mass spectrometry, we identified YTHDF1 as the direct target of LEO. Taken together, we demonstrated that LEO improves oxidative stress and vascular remodeling induced by obesity and targets YTHDF1, raising the possibility of LEO treating other obesity-related metabolic syndromes.https://www.mdpi.com/2076-3921/11/7/1338obesityvascular dysfunctioninflammationoxidative stressLEOYTHDF1
spellingShingle Xiao-Dong Shi
Jia-Xin Zhang
Xi-De Hu
Tao Zhuang
Ning Lu
Cheng-Chao Ruan
Leonurine Attenuates Obesity-Related Vascular Dysfunction and Inflammation
Antioxidants
obesity
vascular dysfunction
inflammation
oxidative stress
LEO
YTHDF1
title Leonurine Attenuates Obesity-Related Vascular Dysfunction and Inflammation
title_full Leonurine Attenuates Obesity-Related Vascular Dysfunction and Inflammation
title_fullStr Leonurine Attenuates Obesity-Related Vascular Dysfunction and Inflammation
title_full_unstemmed Leonurine Attenuates Obesity-Related Vascular Dysfunction and Inflammation
title_short Leonurine Attenuates Obesity-Related Vascular Dysfunction and Inflammation
title_sort leonurine attenuates obesity related vascular dysfunction and inflammation
topic obesity
vascular dysfunction
inflammation
oxidative stress
LEO
YTHDF1
url https://www.mdpi.com/2076-3921/11/7/1338
work_keys_str_mv AT xiaodongshi leonurineattenuatesobesityrelatedvasculardysfunctionandinflammation
AT jiaxinzhang leonurineattenuatesobesityrelatedvasculardysfunctionandinflammation
AT xidehu leonurineattenuatesobesityrelatedvasculardysfunctionandinflammation
AT taozhuang leonurineattenuatesobesityrelatedvasculardysfunctionandinflammation
AT ninglu leonurineattenuatesobesityrelatedvasculardysfunctionandinflammation
AT chengchaoruan leonurineattenuatesobesityrelatedvasculardysfunctionandinflammation